These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
1.
|
To elect Gilberto Tomazoni, Denilson Molina, William W. Lovette, Andre Nogueira de Souza, and Wallim Cruz De Vasconcellos Junior as the five JBS Directors for the ensuing year;
|
2.
|
To elect David E. Bell, Michael L. Cooper, and Charles Macaluso as the three Equity Directors for the ensuing year;
|
3.
|
To conduct a stockholder advisory vote on executive compensation;
|
4.
|
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018;
|
5.
|
To vote on a stockholder proposal, if properly presented, requesting the Board of Directors to adopt and implement a water stewardship policy designed to deduce risks of water contamination from our direct operations and supply chain;
|
6.
|
To vote on a stockholder proposal, if properly presented, regarding Board diversity; and
|
7.
|
To transact such other business as may properly be brought before the meeting or any adjournment thereof.
|
|
|
|
WILLIAM W. LOVETTE
|
Greeley, Colorado
|
|
|
Chief Executive Officer and
|
April 9, 2018
|
|
|
President
|
General Information
|
|
Proposal 1. Election of JBS Directors
|
|
Proposal 2. Election of Equity Directors
|
|
Proposal 3. Advisory Vote on Executive Compensation
|
|
Corporate Governance
|
|
Report of the Compensation Committee
|
|
Compensation Discussion and Analysis
|
|
Executive Compensation
|
|
2017 Director Compensation Table
|
|
Related Party Transactions
|
|
Independent Registered Public Accounting Firm Fee Information
|
|
Report of the Audit Committee
|
|
Proposal 4. Ratification of the Appointment of Independent Registered Public Accounting Firm
|
|
Security Ownership Table
|
|
Equity Compensation Plan Information
|
|
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held
on May 10, 2018
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
|
Householding of Stockholder Materials
|
|
Proposal 5. Stockholder Proposal to Adopt and Implement a Water Stewardship Policy
|
|
Proposal 6. Stockholder Proposal Regarding Board Diversity
|
|
Other Business
|
|
PROXY STATEMENT
|
|
•
|
by completing, dating, signing and mailing the enclosed proxy card;
|
•
|
over the telephone; or
|
•
|
via the internet.
|
Proposal 1:
|
FOR
the election of all five nominees for JBS Director.
|
Proposal 2:
|
FOR
the election of all three nominees for Equity Director.
|
Proposal 3:
|
FOR
the approval of the advisory vote on executive compensation.
|
Proposal 4:
|
FOR
ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018.
|
Proposal 5:
|
AGAINST
the stockholder proposal to adopt and implement a water stewardship policy designed to reduce risks of water contamination from our direct operations and supply chain.
|
Proposal 6:
|
AGAINST
the stockholder proposal regarding Board diversity.
|
Proposal 1:
|
You may either (i) vote “FOR” the election of all JBS Director nominees as a group; (ii) withhold your vote on all JBS Director nominees as a group; or (iii) vote “FOR” the election of all JBS Director nominees as a group except for certain nominees identified by you in the appropriate area on the proxy card or voting instructions.
|
Proposal 2:
|
You may either (i) vote “FOR” the election of all Equity Director nominees as a group; (ii) withhold your vote on all Equity Director nominees as a group; or (iii) vote “FOR” the election of all Equity Director nominees as a group except for certain nominees identified by you in the appropriate area on the proxy card or voting instructions.
|
Proposal 3:
|
Y
ou may vote “FOR” or “AGAINST” the proposal, or you may elect to abstain from voting your shares. Abstaining will have the same effect as a vote against the proposal, as discussed below.
|
Proposal 4:
|
Y
ou may vote “FOR” or “AGAINST” the proposal, or you may elect to abstain from voting your shares. Abstaining will have the same effect as a vote against the proposal, as discussed below.
|
Proposal 5:
|
Y
ou may vote “FOR” or “AGAINST” the proposal, or you may elect to abstain from voting your shares. Abstaining will have the same effect as a vote against the proposal, as discussed below.
|
Proposal 6:
|
You may vote “FOR” or “AGAINST” the proposal, or you may elect to abstain from voting your shares. Abstaining will have the same effect as a vote against the proposal, as discussed below.
|
Proposal 1:
|
FOR
the election of all five nominees for JBS Director.
|
Proposal 2:
|
FOR
the election of all three nominees for Equity Director.
|
Proposal 3:
|
FOR
the approval of the advisory vote on executive compensation.
|
Proposal 4:
|
FOR
ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018.
|
Proposal 5:
|
AGAINST
the stockholder proposal to adopt and implement a water stewardship policy designed to reduce risks of water contamination from our direct operations and supply chain.
|
Proposal 6:
|
AGAINST
the stockholder proposal regarding Board diversity.
|
•
|
by sending to the Secretary of the Company a written notice of revocation that is received prior to the meeting;
|
•
|
by submitting a new proxy card bearing a later date to the Secretary of the Company so that it is received prior to the meeting; or
|
•
|
by attending the meeting and voting your shares in person.
|
•
|
to be an independent director under the NASDAQ listing standards,
|
•
|
to satisfy the independence requirements of Rule 10A-3 under the Exchange Act, and
|
•
|
to be financially literate.
|
•
|
incentive compensation should represent a significant portion of total compensation;
|
•
|
compensation should be performance-based;
|
•
|
incentive compensation should balance short-term and long-term performance;
|
•
|
compensation levels should be market competitive; and
|
•
|
superior performance should be rewarded.
|
•
|
the restriction of our directors, Named Executive Officers, and other key executive officers from hedging the economic interest in the Company securities that they hold;
|
•
|
the prohibition of Company personnel, including the Named Executive Officers, from engaging in any short-term, speculative securities transactions, engaging in short sales, buying or selling put or call options, and trading in options (other than those granted by the Company);
|
•
|
the restriction of our directors, Named Executive Officers, and other key executive officers from pledging the Company securities that they hold; and
|
•
|
our policy of not having any change-in-control or retirement arrangements with our Named Executive Officers.
|
•
|
The Company achieved strong results relating to operating revenues ($10.8 billion), net income ($694.6 million, or $2.79 per diluted share) and net cash provided by operations ($801.3 million).
|
•
|
The Company generated a cumulative total return on its common stock over the five years ended 2017 of 478.7% as compared to a cumulative total return generated over the same period by the Russell 2000 Composite Index and by the Company’s peer group index of 93.6% and 232.8%, respectively. Companies in the peer group index, as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 filed with the SEC on February 16, 2018, include Sanderson Farms Inc., Hormel Foods Corp. and Tyson Foods Inc.
|
•
|
As of our fiscal year ending December 31, 2017, the Company had $589.5 million of cash and cash equivalents.
|
•
|
The Company continued its efforts on cost reductions, more effective processes, training and its total quality management program. Between 2011 and 2017, these efforts have resulted in cumulative operational improvements of approximately $1.1 billion.
|
•
|
Incentive compensation should represent a significant portion of total compensation
. A significant portion of our executives’ total compensation should be tied not only to how well they perform individually, but also, where applicable, should be “at risk” based on how well the Company performs relative to applicable financial objectives.
|
•
|
Compensation should be performance-based
. Compensation should be subject to performance-based awards as an executive officer’s range of responsibility and ability to influence the Company’s results increase.
|
•
|
Incentive compensation should balance short-term and long-term performance.
Executive compensation should be linked to building long-term stockholder value while remaining consistent with our business objectives and values. Our executive compensation program addresses this objective by including long-term incentives in the form of equity-based awards, such as restricted common stock and restricted stock units, which makes the performance of the Company’s common stock a targeted incentive.
|
•
|
Compensation levels should be market competitive
. Compensation should be competitive in relation to the marketplace. Prior to setting performance goals and target opportunities for our incentive compensation, the Compensation Committee considers market compensation data compiled and prepared by management.
|
•
|
Superior performance should be rewarded
. Outstanding achievement should be recognized. The Board and the Compensation Committee consider the Company’s strategies when identifying the appropriate incentive measures and when assigning individual goals and objectives to the Named Executive Officers and evaluate the individual’s performance against those strategies in setting compensation.
|
•
|
a survey of Russell 3000 index companies, sorted by size and industry.
|
•
|
base salaries;
|
•
|
bonuses, including annual cash incentive compensation and discretionary bonuses;
|
•
|
long-term incentive compensation, including awards of restricted stock units earned and granted based on the achievement of performance goals, time-vested restricted stock and restricted stock units;
|
•
|
a discretionary award of time based restricted stock units;
|
•
|
other compensation consisting primarily of health and welfare benefits; and
|
•
|
certain limited perquisites and other personal benefits.
|
Payout (as a percentage of award target)
|
50%
|
|
75%
|
|
100%
|
|
125%
|
|
150%
|
EBIT delta to average company
(a)
|
+1.80
|
|
+1.90
|
|
+2.00
|
|
+2.10
|
|
+2.20
|
(a)
|
Cents per processed pound.
|
•
|
the Company’s strong performance relative to its competitors in 2017;
|
•
|
that the Named Executive Officers had not received equity awards under our long-term incentive program over the past three years, despite strong Company performance;
|
•
|
that the principle of rewarding and incentivizing superior performance is undermined by not delivering equity awards under our long-term incentive programs in years where the Company outperformed its competitors; and
|
2017 PBT Margin
|
|
Bonus Amount
|
3% (Threshold)
|
|
$250,000
|
4%
|
|
$500,000
|
5%
|
|
$750,000
|
6% (Target)
|
|
$1,000,000
|
7%
|
|
$1,250,000
|
8%
|
|
$1,500,000
|
9%
|
|
$1,750,000
|
10%
|
|
$2,000,000
|
Greater than 10%
|
|
$2,000,000
plus
1.0% of the excess PBT above 10% |
•
|
Reduction of capital employed;
|
•
|
Integration synergies;
|
•
|
Finance budget;
|
•
|
Key employee retention;
|
•
|
Audit compliance;
|
•
|
Reduction of cost of capital; and
|
•
|
Relative position against industry.
|
2017 PBT Margin
|
|
Bonus as % of Base Salary
|
3% (Threshold)
|
|
25%
|
4%
|
|
50%
|
5%
|
|
75%
|
6% (Target)
|
|
100%
|
7%
|
|
125%
|
8%
|
|
150%
|
9%
|
|
175%
|
10%
|
|
200%
|
Greater than 10%
|
|
200% plus
0.2% of the excess PBT above 10%
|
Name and Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock Awards
(a)
($)
|
Non-Equity
Incentive
Plan
Compensation
(b)
($)
|
All Other Compensation
(c)
($)
|
Total
($)
|
||||||
William W. Lovette
|
2017
|
1,000,000
|
|
—
|
|
—
|
|
2,897,000
|
|
4,065
|
|
3,901,065
|
|
Chief Executive Officer and President
|
2016
|
1,000,000
|
|
—
|
|
—
|
|
1,500,000
|
|
475,725
|
|
2,975,725
|
|
|
2015
|
1,038,462
|
|
—
|
|
—
|
|
4,537,000
|
|
977,875
|
|
6,553,337
|
|
Fabio Sandri
|
2017
|
421,923
|
|
—
|
|
—
|
|
983,946
|
|
15,712
|
|
1,421,581
|
|
Chief Financial Officer
|
2016
|
407,500
|
|
—
|
|
—
|
|
590,212
|
|
205,534
|
|
1,203,246
|
|
|
2015
|
415,385
|
|
420,150
|
|
—
|
|
800,000
|
|
381,810
|
|
2,017,345
|
|
(a)
|
In January 2017, Mr. Lovette and Mr. Sandri received performance-based awards under the 2017 Program that would be settled for RSUs if the awards were earned. At the date of receipt of the grants, the outcome of achieving the performance conditions was deemed improbable. Had the awards been earned at the maximum level, they would have been valued at $1,500,000 and $622,500 for Mr. Lovette and Mr. Sandri, respectively, based on the closing price of the Company’s common stock at $19.62 per share. The performance conditions pertaining to the 2017 Program awards were not achieved. See “Compensation Discussion and Analysis - Components of Compensation - Long-Term Incentive Compensation,” “Compensation Discussion and Analysis - Compensation to William W. Lovette - Long-Term Incentive Compensation” and “Compensation Discussion and Analysis - Compensation to Fabio Sandri - Long-Term Incentive Compensation” for discussions of the applicable performance conditions.
|
(b)
|
The amounts received by Mr. Lovette and Mr. Sandri for 2017 reflect cash bonuses received pursuant to the STIP. See “Compensation Discussion and Analysis - Compensation to William W. Lovette - Base Salary and Annual Incentive Compensation” and “Compensation Discussion and Analysis - Compensation to Fabio Sandri - Base Salary and Annual Incentive Compensation” for a discussion of the performance metrics related to these STIP awards.
|
(c)
|
For 2017, the “All Other Compensation” column includes the following items of compensation:
|
i.
|
Section 79 income to the named individuals due to group term life insurance in the following amounts: William W. Lovette, $2,322; and Fabio Sandri, $669.
|
ii.
|
The Company reimburses employees for a portion of their long-term disability premium cost. William W. Lovette received $543 for a portion of his long-term disability premium cost.
|
iii.
|
The Company provides a cell phone stipend to employees to cover business use on personal cell phones. William W. Lovette received $1,200 and Fabio Sandri received $600 in stipends.
|
iv.
|
The Company provides matching 401(k) contributions. Fabio Sandri received $2,297 in matching contributions. Mr. Lovette did not contribute to this plan in 2017.
|
v.
|
The Company provides matching Deferred Compensation Plan contributions. Fabio Sandri received $12,146, $19,518 and $4,800 in matching contributions in 2017, 2016, and 2015, respectively. Mr. Lovette did not contribute to this plan.
|
Name
|
Grant
Date
|
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards
(a)
|
Estimated Future Payouts Under Equity Incentive Plan Awards
(b)
|
All Other Stock Awards: Number of Shares of Stock or Units
(#)
|
Grant Date Fair Value of Stock and Option Awards
($)
|
||||||||||||
|
|
Threshold
($)
|
Target
($)
|
Maximum
($)
|
Threshold
(#)
|
Target
(#)
|
Maximum
(#)
|
|
|
||||||||
William W. Lovette
|
12/09/2016
|
500,000
|
|
1,000,000
|
|
10,000,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
01/19/2017
|
—
|
|
—
|
|
—
|
|
25,491
|
|
50,981
|
|
76,472
|
|
—
|
|
—
|
|
Fabio Sandri
|
12/09/2016
|
103,750
|
|
415,000
|
|
830,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
01/19/2017
|
—
|
|
—
|
|
—
|
|
10,576
|
|
21,152
|
|
31,728
|
|
—
|
|
—
|
|
(a)
|
The amounts reported in these columns reflect the threshold, target and maximum amounts available under the STIP. For each of Mr. Lovette and Mr. Sandri, threshold, target and maximum amounts under the STIP were determined by the Compensation Committee in December 2016. See “Compensation Discussion and Analysis - Compensation to William W. Lovette - Base Salary and Annual Incentive Compensation” and “Compensation Discussion and Analysis - Compensation to Fabio Sandri - Base Salary and Annual Incentive Compensation” for discussions of the applicable performance targets.
|
(b)
|
In January 2017, Mr. Lovette and Mr. Sandri received performance-based awards under the 2017 Program that would be settled for RSUs if the awards were earned. At the date of receipt of the grants, the outcome of achieving the performance conditions was deemed improbable. Had the awards been earned at the maximum level, they would have been valued at $1,500,000 and $622,500 for Mr. Lovette and Mr. Sandri, respectively, based on the closing price of the Company’s common stock at $19.62 per share. The performance conditions pertaining to the 2017 Program awards were not achieved. See “Compensation Discussion and Analysis - Components of Compensation - Long-Term Incentive Compensation,” “Compensation Discussion and Analysis - Compensation to William W. Lovette - Long-Term Incentive Compensation” and “Compensation Discussion and Analysis - Compensation to Fabio Sandri - Long-Term Incentive Compensation” for discussions of the applicable performance conditions.
|
|
Stock Awards
|
||||||||||
Name
|
Number of Shares or Units of Stock That Have Not Vested
(#)
|
|
Market Value of Shares or Units of Stock That Have Not Vested
($)
|
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#)
|
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested
($)
|
||||
William W. Lovette
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Fabio Sandri
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|||||
Name
|
Executive Contributions in Last Fiscal Year ($)(a)
|
Registrant Contributions in Last Fiscal Year ($)(b)
|
Aggregate Earnings (Loss) in Last Fiscal Year ($)(c)
|
Aggregate Withdrawals/ Distributions ($)
|
Aggregate Balance at Last Fiscal Year End ($)(d)
|
|||||
William W. Lovette
|
|
|
|
|
|
|||||
Deferred Compensation Plan
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Fabio Sandri
|
|
|
|
|
|
|||||
Deferred Compensation Plan
|
30,364
|
|
12,146
|
|
19,347
|
|
—
|
|
161,316
|
|
(a)
|
Amounts in this column for the Deferred Compensation Plan represent salary deferrals pursuant to the Deferred Compensation Plan and are included in the “Salary” amounts in the Summary Compensation Table above.
|
(b)
|
Amounts in this column for the Deferred Compensation Plan represent company-matching awards pursuant to the Deferred Compensation Plan and are included in the “All Other Compensation” amounts in the Summary Compensation Table above.
|
(c)
|
There were no above-market or preferential earnings with respect to any deferred compensation balances.
|
(d)
|
The Company provides matching Deferred Compensation Plan contributions. Mr. Sandri received $12,146, $19,518 and $4,800 in matching contributions in 2017, 2016, and 2015, respectively, and as a result were included as compensation in the Summary Compensation Table in previous years for the year earned, as applicable.
|
Executive Officer / Element of Compensation
|
|
Termination due to Death or
Disability
($)
|
|
Termination Other than for Cause,
Death or
Disability
($)
|
|
Change-in-Control
($)
|
|||
William W. Lovette
|
|
|
|
|
|
|
|||
Severance payment
(a)
|
|
—
|
|
|
2,000,000
|
|
|
—
|
|
Self-insured payments
(b)(c)
|
|
346,154
|
|
|
—
|
|
|
—
|
|
Immediate vesting of RSUs
(d)
|
|
—
|
|
|
—
|
|
|
—
|
|
Total for Mr. Lovette
|
|
346,154
|
|
|
2,000,000
|
|
|
—
|
|
|
|
|
|
|
|
|
|||
Fabio Sandri
|
|
|
|
|
|
|
|||
Severance payment
(a)
|
|
—
|
|
|
200,962
|
|
|
—
|
|
Self-insured payments
(b)
|
|
164,423
|
|
|
—
|
|
|
—
|
|
Immediate vesting of RSUs
(d)
|
|
—
|
|
|
—
|
|
|
—
|
|
Total for Mr. Sandri
|
|
164,423
|
|
|
200,962
|
|
|
—
|
|
(a)
|
Calculated pursuant to the Severance Plan, as described below.
|
(b)
|
Amounts in the table reflect lump-sum payments to be made by the Company. For termination due to death, Mr. Lovette’s and Mr. Sandri’s estates would also receive $500,000 and $475,000, respectively, from third-party insurers.
|
(c)
|
Mr. Lovette would also receive approximately $15,000 per month in long-term disability payments from third-party insurers.
|
(d)
|
At December 31, 2017 Mr. Lovette and Mr. Sandri had no equity incentive plan awards that had not vested.
|
•
|
elements that balance short-term and long-term compensation;
|
•
|
for our executive officers, incentive compensation that rewards performance based on Company performance; and
|
•
|
compensation with fixed and variable components.
|
Director
|
|
Fees Earned or Paid in Cash
|
|
All Other Compensation
|
|
Total
|
||||||
David E. Bell
|
|
$
|
232,000
|
|
|
$
|
—
|
|
|
$
|
232,000
|
|
Michael L. Cooper
|
|
287,250
|
|
|
—
|
|
|
287,250
|
|
|||
Tarek Farahat
(a)
|
|
38,000
|
|
|
|
|
38,000
|
|
||||
Charles Macaluso
|
|
250,500
|
|
|
—
|
|
|
250,500
|
|
|||
Wallim Cruz Vasconcellos Junior
|
|
217,000
|
|
|
—
|
|
|
217,000
|
|
(a)
|
Tarek Farahat resigned from the Board of Directors in February 2018.
|
•
|
a recommendation by the Chief Financial Officer (or designee) as to whether the Audit Committee should approve the request or application; and
|
•
|
a joint statement of the Chief Financial Officer (or designee) and the independent registered public accounting firm as to whether, in their view, the request or application is consistent with the SEC’s regulations and the requirements for auditor independence of the Public Company Accounting Oversight Board.
|
•
|
pre-approve any services proposed to be provided by the independent registered public accounting firm and not already pre-approved or prohibited by this policy up to $25,000;
|
•
|
increase any authorized fee limit for pre-approved services (but not by more than 30% of the initial amount that was pre-approved) before we or our subsidiaries engage the independent registered public accounting firm to perform services for any amount in excess of the fee limit; and
|
•
|
investigate further the scope, necessity or advisability of any services as to which pre-approval is sought.
|
1.
|
The Audit Committee has reviewed and discussed the audited financial statements with the Company’s management.
|
2.
|
The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by Statement on Accounting Standards No. 61, as amended (AICPA, Professional Standards, Vol. 1. AU Section 380) as adopted by the Public Company Accounting Oversight Board in Rule 3200T.
|
3.
|
The Audit Committee has received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence and has discussed with the independent registered public accounting firm the independent registered public accounting firm’s independence.
|
4.
|
Based on the review and discussions set forth above, the Audit Committee recommended to the Board that the audited financial statements be included in the Company’s annual report on Form 10-K for the year ended December 31, 2017 that was filed with the SEC and that accompanies this proxy statement.
|
|
Audit Committee
|
|
Michael L. Cooper, Chairman
Charles Macaluso
Wallim Cruz De Vasconcellos Junior
|
Name and Beneficial Owner
|
|
Amount and Nature of Beneficial Ownership of Common Stock
|
|
Percent of Outstanding Common Stock
|
|
Percent of Voting Power
|
|||
JBS USA Holding Lux S.
à
r.l.
(a)
|
|
195,445,936
|
|
|
78.50
|
%
|
|
78.50
|
%
|
William W. Lovette
|
|
578,653
|
|
|
*
|
|
|
*
|
|
Fabio Sandri
|
|
201,073
|
|
|
*
|
|
|
*
|
|
Michael L. Cooper
|
|
4,885
|
|
|
*
|
|
|
*
|
|
David E. Bell
|
|
2,000
|
|
|
*
|
|
|
*
|
|
Denilson Molina
|
|
—
|
|
|
*
|
|
|
*
|
|
Gilberto Tomazoni
|
|
—
|
|
|
*
|
|
|
*
|
|
Charles Macaluso
|
|
—
|
|
|
*
|
|
|
*
|
|
Andre Nogueira de Souza
|
|
—
|
|
|
*
|
|
|
*
|
|
Wallim Cruz De Vasconcellos Junior
|
|
—
|
|
|
*
|
|
|
*
|
|
All executive officers and Directors as a group (8)
(a)
|
|
196,232,547
|
|
|
78.81
|
%
|
|
78.81
|
%
|
(a)
|
JBS USA Holding Lux S.
à
r.l. (formerly known as JBS USA Holdings, Inc.) is a wholly owned, indirect subsidiary of JBS and indirectly beneficially owns 195,445,936 shares of our common stock. JBS is ultimately controlled by the Batista family, which is comprised of José Batista Sobrinho, the founder of JBS, Flora Mendonça Batista, and five of their children, Valére Batista Mendonça Ramos, Vanessa Mendonça Batista, Wesley Mendonça Batista, Joesley Mendonça Batista and Vivianne Mendonça Batista Silveira. The Batista family indirectly owns 100% of the issued and outstanding shares of J&F Investimentos S.A., a Brazilian corporation, which owns approximately 40.64% of the outstanding capital of JBS. Additionally, the Batista family controls Banco Original S.A. and Banco Original do Agronegócio S.A., Brazilian corporations which own 1.23% and 0.03% of the outstanding capital of JBS, respectively.
|
Plan Category
|
|
Number of Securities
to Be Issued Upon
Exercise of
Outstanding
Options, Warrants
and Rights
(#)
|
|
Weighted-Average
Exercise Price of
Outstanding
Option, Warrants
and Rights
($)
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the First Column)
(#)
|
|||
Equity compensation plans approved by securities holders
|
|
—
|
|
|
—
|
|
|
4,825,825(a)
|
|
Equity compensation plans not approved by securities holders
|
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
|
—
|
|
|
—
|
|
|
4,825,825
|
|
(a)
|
Represents shares of our common stock that may be issued under the LTIP. As of December 31, 2017, the Company has granted an aggregate of 102,675 shares of restricted stock and 2,495,669 RSUs under the LTIP. As of December 31, 2017, no other awards have been issued under the LTIP. For additional information concerning terms of the LTIP, see “Compensation Discussion and Analysis - Components of Compensation - Long Term Incentive Plan” and “Executive Compensation - Long Term Incentive Plan.”
|
1.
|
Go to
www.envisionreports.com/PPC
.
|
2.
|
Enter the 12-digit control number located on the proxy card.
|
3.
|
Click “View Stockholder Material.”
|
•
|
Requirements for leading practices for nutrient management and pollutant limits throughout direct operations, contract farms, and feed suppliers, with a focus on verifiably reducing nitrate contamination;
|
•
|
Reporting on time-bound goals, key performance indicators and metrics demonstrating conformance to the policy;
|
•
|
Financial and technical support to help suppliers implement the policy; and
|
•
|
A transparent mechanism to regularly disclose progress on adoption and implementation.
|
1.
|
The consideration of modifications to nominating and corporate governance policies reflecting greater commitment to advancing Board diversity inclusive of gender, race, and ethnicity;
|
2.
|
The inclusion of women and minority candidates in every pool from which Board nominees are chosen; and
|
3.
|
An assessment of challenges experienced and progress achieved.
|
|
|
By order of the Board of Directors,
|
|
|
|
|
|
|
|
|
WILLIAM W. LOVETTE
|
Greeley, Colorado
|
|
Chief Executive Officer and
|
April 9, 2018
|
|
President
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|